References
- Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open 2014 Feb 12;4(2):e004015.
- Bennett J, Wellman J, Marshall KA, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet 2016 Aug 13;388(10045):661–672.
- Ghazi NG, Abboud EB, Nowilaty SR, et al. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum Genet 2016 Mar;135(3):327–343.
- MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 2014 Mar 29;383(9923):1129–1137.
- Retinitis pigmentosa. (2016). Orphanet: retinitis pigmentosa. [online] Orpha.net. Available at: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=791 [Accessed 13 Sep. 2016].
- Chakarova CF, Khanna H, Shah AZ, et al. TOPORS, implicated in retinal degeneration, is a cilia-centrosomal protein. Hum Mol Genet. 2011 Mar 1;20(5):975–987.
- Czub B, Shah AZ, Alfano G, et al. TOPORS, a Dual E3 Ubiquitin and Sumo1 ligase, interacts with 26 S protease regulatory Subunit 4, encoded by the PSMC1 Gene. PLoS One 2016 Feb 12;11(2):e0148678.
- Chakarova CF, Papaioannou MG, Khanna H, et al. Mutations in TOPORS cause autosomal dominant retinitis pigmentosa with perivascular retinal pigmentepithelium atrophy. Am J Hum Genet 2007 Nov;81(5):1098–1103.
- Papaioannou M, Chakarova CF, Prescott DC, et al. A new locus (RP31) for autosomal dominant retinitis pigmentosa maps to chromosome 9p. Hum Genet 2005 Dec;118(3–4):501–503.
- Bowne SJ, Sullivan LS, Gire AI, et al. Mutations in the TOPORS gene cause 1% of autosomal dominant retinitis pigmentosa. Mol Vis 2008 May 19;14:922–927.
- Schob C, Orth U, Gal A, et al. Mutations in TOPORS: a rare cause of autosomal dominant retinitis pigmentosa in continental Europe? Ophthalmic Genet 2009 Jun;30(2):96–98.
- Jaissle GB, May CA, van de Pavert SA, et al. Bone spicule formation in retinitis pigmentosa: insights from a mouse model. Graefes Arch Clin Exp Ophthalmol 2010;248:1063–1070.
- Delori FC, Goger DG, Dorey CK. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 2001 Jul;42(8):1855–1866.
- Robson AG, Michaelides M, Luong VA, et al. Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol 2008 Jan;92(1):95–102. Epub 2007 Oct 25.
- Scholl HP, Chong NH, Robson AG, et al. Fundus autofluorescence in patients with Leber congenital amaurosis. Invest Ophthalmol Vis Sci 2004 Aug;45(8):2747–2752.
- Jarc-Vidmar M, Kraut A, Hawlina M. Fundus autofluorescence imaging in Best’s vitelliform dystrophy. Klin Monbl Augenheilkd 2003 Dec;220(12):861–867.
- Tsang SH, Vaclavik V, Bird AC, et al. Novel phenotypic and genotypic findings in X-linked retinoschisis. Arch Ophthalmol 2007 Feb;125(2):259–267.
- Downes SM, Holder GE, Fitzke FW, et al. Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol 2001 Jan;119(1):96–105.
- Downes SM, Payne AM, Kelsell RE, et al. Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol 2001 Nov;119(11):1667–1673.
- Selmer KK, Grøndahl J, Riise R, et al. Autosomal dominant pericentral retinal dystrophy caused by a novel missense mutation in the TOPORS gene. Acta Ophthalmol 2010 May;88(3):323–328.